Atogepant, 100mg

Atogepant, 100mg

YD23, 25mg

YD23, 25mg

YD23, 5mg

1.501,78 RON
SKU
SKM_E1985_5mg

YD23 is a PROTAC which induces the degradation of SMARCA2. It reduces chromatin accessibility in SMARCA4-deficient cells, affecting gene enhancers related to cell cycle and growth regulation, which leads to the downregulation of several cell cycle genes. It also selectively inhibits the growth of SMARCA4 mutant lung cancer cells in vitro.

Mai multe informatii
Price 1.262,00 RON (preturile sunt fara TVA)
Description

YD23 is a PROTAC which induces the degradation of SMARCA2. It reduces chromatin accessibility in SMARCA4-deficient cells, affecting gene enhancers related to cell cycle and growth regulation, which leads to the downregulation of several cell cycle genes. It also selectively inhibits the growth of SMARCA4 mutant lung cancer cells in vitro.